← signals
2026-07-15·NVDA·competitive threat
lowdown

Multiple Manifold Markets prediction questions indicate growing market belief that Chinese AI chipmakers will erode...

Multiple Manifold Markets prediction questions indicate growing market belief that Chinese AI chipmakers will erode Nvidia's dominance.

window 90devidence 27confidence score 91price NVDA $211.80

confidence score

Strong evidence: 1 independent source class support this read.

91
low confidence1 independent source classesmarketpasses publish gate
priced-in check

NVDA has not made a large direction-matching 30-90 day move yet.

not priced in
as of 2026-07-147d n/a45d n/a90d +7%yahoo

signal brief

Multiple Manifold Markets prediction questions indicate growing market belief that Chinese AI chipmakers will erode Nvidia's dominance. Source 11 (https://manifold.markets/HenriThunberg/3-chinas-ai-chip-sector-make-signif) shows 74.9% consensus that China's AI chip sector will make significant strides, planting seeds for Nvidia's decline. Source 19 (https://manifold.markets/SimranRahman/will-a-serious-competitor-to-nvidia) has 72.9% betting a serious competitor emerges by end of 2027. Source 25 (https://manifold.markets/JankoPrester/will-china-develop-domestic-gpu-wit) gives 24.5% for a Chinese GPU matching H100 performance by 2026. Meanwhile, regulatory easing for Nvidia's China sales remains unlikely, with only 11% (Source 8, https://manifold.markets/NoaNabeshima/will-nvidia-resume-selling-its-top) and 19% (Source 14, https://manifold.markets/JamesSanders/nvidia-allowed-to-sell-b30a-to-chin) expecting resumption of top GPU sales or B30A approval by 2027.

What the sources said:

  • Source 11: "74.9% YES on China's AI chip sector making significant strides, planting seeds for eventual decline on Nvidia."
  • Source 19: "72.9% YES on a serious competitor to NVIDIA in AI chips emerging before EOY 2027."
  • Source 8: "Only 11% YES on Nvidia resuming top GPU sales to China by April 1, 2027."
  • Source 25: "24.5% YES on China developing domestic GPU comparable to H100 by 2026."

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.